Metabolic Dysfunction Associated Steatotic Liver Disease, Not Just Fatty Liver Disease: A Systemic Shift in Naming and Understanding

Authors

DOI:

https://doi.org/10.3126/jonmc.v14i2.87484

Keywords:

Medicine, Metabolic Diseases, Non-alcoholic Fatty Liver Disease

Abstract

The reclassification of fatty liver disease to Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) marks a paradigm shift. Moving beyond stigmatizing, misleading terms, MASLD emphasizes metabolic dysfunction as the root cause. This systemic condition links to cardiovascular, renal, and diabetic risks, demanding comprehensive screening, research, and public health action worldwide.

Downloads

Download data is not yet available.
Abstract
0
PDF
0

Author Biography

Pratap Sagar Tiwari, Department of Hepatology, Nobel Medical College Teaching Hospital, Biratnagar, Nepal

Associate Professor

Cover JoNMC

Downloads

Published

2025-12-31

How to Cite

Tiwari, P. S. (2025). Metabolic Dysfunction Associated Steatotic Liver Disease, Not Just Fatty Liver Disease: A Systemic Shift in Naming and Understanding. Journal of Nobel Medical College, 14(2), 1–2. https://doi.org/10.3126/jonmc.v14i2.87484

Issue

Vol. 14 No. 2 (2025)

Section

Editorial

License

Copyright (c) 2025 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

JoNMC applies the Creative Commons Attribution (CC BY) license to works we publish. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited.